| Mrs Anita Sue Collins, LPN | |
|
Rr 1 Box 2400, Dora, MO 65637-9305 | |
| (417) 712-1705 | |
| Not Available |
| Full Name | Mrs Anita Sue Collins |
|---|---|
| Gender | Female |
| Speciality | Licensed Practical Nurse |
| Location | Rr 1 Box 2400, Dora, Missouri |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1801175724 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 164W00000X | Licensed Practical Nurse | 042159 (Missouri) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Anita Sue Collins, LPN Rr 1 Box 2400, Dora, MO 65637 Ph: (417) 712-1705 | Mrs Anita Sue Collins, LPN Rr 1 Box 2400, Dora, MO 65637-9305 Ph: (417) 712-1705 |
News Archive
Sandy has come and gone in New York, leaving a trail of disaster behind, and few know this better than elderly residents in impacted areas. With often times limited mobility, delayed reaction, and reliance on prescriptions for their health, when disaster strikes, the elderly are left struggling.
The National Institute of Dental and Craniofacial Research, a division of the National Institutes of Health, has awarded NYU College of Dentistry Professors Deepak Saxena, MS, PhD, and Xin Li, PhD, a four-year $1.6M NIDCR grant to study the biological and physiological effects of electronic cigarette aerosol mixtures on oral health.
According to HSE researchers, men with a high 2D:4D ratio (i.e. those whose index finger is longer than their ring finger) tend to be better educated. These findings are presented in the paper "2D: 4D and lifetime educational outcomes: Evidence from the Russian RLMS survey" in Personality and Individual Differences.
Accretive Health, Inc., a provider of end-to-end revenue cycle management services for U.S. healthcare providers today announced the initial public offering of 10,000,000 shares of its common stock at a price to the public of $12.00 per share. Of the 10,000,000 shares being offered to the public, 6,666,667 shares are being offered by Accretive Health and 3,333,333 shares are being offered by selling stockholders.
Vertellus Specialties Inc. announced today that it will break ground on a new 3-cyanopyridine production unit at Vertellus' production facility in Nantong, Jiangsu, China. This unit is a continuation of a larger effort to expand production capacity in Nantong. It will increase Vertellus' Vitamin B3 manufacturing capacity in the region by 10,000 metric tons. The capacity increase will enable Vertellus to maintain its position as the world's second largest provider of Vitamin B3 and the largest producer of cyanopyridines in the world.
› Verified 4 days ago